🔗 Visit the ClinicalTrials.gov page for NCT01470859
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Changes in network activity with the progression of Parkinson's disease. | Brain | 2007 | 2.46 |
| 2 | Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility. | J Cereb Blood Flow Metab | 2006 | 2.42 |
| 3 | A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study. | Arch Neurol | 2005 | 1.62 |
| 4 | Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease. | J Neurosci | 2010 | 1.50 |
| 5 | Modulation of metabolic brain function by bilateral subthalamic nucleus stimulation in the treatment of Parkinson's disease. | J Neurol | 2009 | 0.93 |
| 6 | Novel neuroprotective mechanisms of pramipexole, an anti-Parkinson drug, against endogenous dopamine-mediated excitotoxicity. | Eur J Pharmacol | 2006 | 0.79 |